Novartis Investigative Site

Albacete, Castille-La Mancha 02006

1 studies enrolling now · 4 studies all time

What they study most

Relapsing Multiple Sclerosis, Sarcopenia, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed